Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darragh Twomey

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of the American College of Cardiology|December 3, 2014
Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort studyRajeev K Pathak, Melissa E Middeldorp, Dennis H Lau, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Cost-Effectiveness and Clinical Effectiveness of the Risk Factor Management Clinic in Atrial Fibrillation: The CENT StudyRajeev K Pathak, Michelle Evans, Melissa E Middeldorp, et al.
International Journal of Cardiology|May 13, 2015
Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous AustraliansChristopher X Wong, Sarah W Lee, Siang Wei Gan, et al.
JAMA Network Open|April 21, 2026
Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction: A Secondary Analysis of the SENIOR-RITA Randomized Clinical TrialFrancesca Rubino, Helen Mossop, David P Ripley, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2018
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF studyMelissa E Middeldorp, Rajeev K Pathak, Megan Meredith, et al.
Cardiovascular Research|February 1, 2021
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmiasLarry Scott, Anke C Fender, Arnela Saljic, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of the American College of Cardiology|December 3, 2014
Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort studyRajeev K Pathak, Melissa E Middeldorp, Dennis H Lau, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Cost-Effectiveness and Clinical Effectiveness of the Risk Factor Management Clinic in Atrial Fibrillation: The CENT StudyRajeev K Pathak, Michelle Evans, Melissa E Middeldorp, et al.
International Journal of Cardiology|May 13, 2015
Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous AustraliansChristopher X Wong, Sarah W Lee, Siang Wei Gan, et al.
JAMA Network Open|April 21, 2026
Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction: A Secondary Analysis of the SENIOR-RITA Randomized Clinical TrialFrancesca Rubino, Helen Mossop, David P Ripley, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2018
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF studyMelissa E Middeldorp, Rajeev K Pathak, Megan Meredith, et al.
Cardiovascular Research|February 1, 2021
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmiasLarry Scott, Anke C Fender, Arnela Saljic, et al.
Pageof 2